Replimune Group REPL Net Amortization Of Premiums And Discounts On Short-term Investments

Net Amortization Of Premiums And Discounts On Short-term Investments at other companies

Personalis, Inc.PSNL

$1.13M+3.8%

Prime MedicinePRME

$312K-24.1%

Prime MedicinePRME

$312K-24.1%

Sarepta Therapeutics, Inc.SRPT

$955K-49.4%

Sarepta Therapeutics, Inc.SRPT

$955K-49.4%

CNX

PC ConnectionCNXN

$142.25K—

FAQ

What is Replimune Group's net amortization of premiums and discounts on short-term investments?

Replimune Group (REPL) reported net amortization of premiums and discounts on short-term investments of $134K in Q4 2025.

How has Replimune Group's net amortization of premiums and discounts on short-term investments changed year-over-year?

Replimune Group's net amortization of premiums and discounts on short-term investments decreased by 92.5% year-over-year, from $1.79M to $134K.

What is the long-term trend for Replimune Group's net amortization of premiums and discounts on short-term investments?

Over 3 years (2022 to 2025), Replimune Group's net amortization of premiums and discounts on short-term investments has grown at a 59.1% compound annual growth rate (CAGR), from -$2.22M to $8.95M.

What does net amortization of premiums and discounts on short-term investments mean?

This represents the non-cash adjustment to net income resulting from the amortization of premiums or accretion of discounts on short-term investment securities. It reflects the difference between the purchase price and the face value of debt instruments held as investments, recognized over the life of the security. This adjustment is necessary to reconcile net income with cash flows from operating activities.